1Y Target$64.41Near-term target
5Y Target$90.20Compound horizon
10Y Target$132.60Long-dated conviction
FCF—TTM—FCF not applicable for this sector (bank / insurer / REIT) or data unavailable
Rev+47.4%TTM YoYARevenue +47.4% — hypergrowth, top decile
D/E0.00AD/E 0.00 — essentially debt-free, pristine balance sheet
P/E9.3xA-P/E 9.3 — cheap relative to market and most sectors
PEG0.20proxyAPEG 0.20 — exceptional; paying well under fair value for growth · PEG proxy: P/E ÷ revenue growth % (true PEG requires forward EPS estimates, not in Finnhub free tier).
Why now
Banking · market cap $2.2b. 3% off the 52-week high of $57.84. Revenue growing +47% — in hypergrowth territory. PEG 0.20 — paying under fair value for the growth rate.
Moat
Net margin 40% is exceptional — pricing-power territory rare outside premium software, branded staples, and specialty pharma. ROE 22% sits above Buffett's preferred 15% threshold — the equity base is compounding at a rate the market struggles to discount accurately. Financial moat — scale of deposit base / underwriting franchise plus regulatory capital advantages. The largest players compound book value through cycles that erase smaller competitors.
Risk
Regulatory capital risk — stricter capital requirements (CCAR, Basel) can force a dividend cut or a capital raise; the largest banks are most exposed because they're held to the tightest standards.
Horizon
1-3 yr $64.41 (structural (no analyst coverage)) — fundamentals + valuation re-rating. 5 yr $90.20 at ~10% CAGR — compounding case rests on the competitive position widening. 10 yr $132.60 if current growth sustains into durable earnings power.
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See
terms and
methodology for full disclosures.